Article Information
PubMed
Published By
History
- Received July 2, 2012
- Revision received January 10, 2013
- Accepted January 16, 2013
- First published March 6, 2013.
- Version of record published March 6, 2013.
Copyright & Usage
Copyright © 2013 the authors 0270-6474/13/334494-11$15.00/0
Author Information
- Sara C. Mednick1,2,3,
- Elizabeth A. McDevitt1,
- James K. Walsh4,5,
- Erin Wamsley6,
- Martin Paulus2,3,
- Jennifer C. Kanady7, and
- Sean P. A. Drummond2,3
- 1Department of Psychology, University of California Riverside, Riverside, California 92521,
- 2Department of Psychiatry, University of California San Diego, La Jolla, California 92093,
- 3VA San Diego Healthcare System, La Jolla, California 92161,
- 4St. Luke's Hospital, St. Louis, Missouri 64111,
- 5Department of Psychiatry, Stanford University, Palo Alto, California 94305,
- 6Department of Psychiatry, Harvard Medical School, Boston, Massachusetts 02115, and
- 7Department of Psychology, University of California Berkeley, Berkeley, California 94720
Author contributions
Author contributions: S.C.M., J.K.W., M.P., and S.P.A.D. designed research; S.C.M., E.A.M., and J.C.K. performed research; S.C.M., E.A.M., and E.W. analyzed data; S.C.M., E.A.M., J.K.W., E.W., M.P., J.C.K., and S.P.A.D. wrote the paper.
Disclosures
- Received July 2, 2012.
- Revision received January 10, 2013.
- Accepted January 16, 2013.
This work was supported by NIMH Grant K01MH080992 (S.C.M.) and National Science Foundation Award 0729021 (S.P.A.D.). J.K.W. was supported by Pfizer Merck & Co., Somnus, Vanda, Neurogen, sanofi-aventis, Ventus, Respironics, Apnex, and Jazz Pharmaceuticals. Jazz Pharmaceuticals provided the sodium oxybate.
J.K.W. has provided consulting services to Pfizer, sanofi-aventis, Respironics, Transcept, Neurogen, GlaxoSmithKline, Eli Lilly, Merck, Kingsdown, Vanda, Ventus, Vivus, and Somnus.
- Correspondence should be addressed to Sara C. Mednick at the above address. smednick{at}ucr.edu
Online Impact
